Sabra Health Care REIT (SBRA) to Release Earnings on Wednesday

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) is expected to be issuing its quarterly earnings data after the market closes on Wednesday, February 19th. Analysts expect the company to announce earnings of $0.36 per share and revenue of $178.01 million for the quarter. Investors interested in participating in the company's conference call can do so using this link.

Sabra Health Care REIT Trading Down 1.0 %

NASDAQ SBRA traded down $0.16 on Friday, hitting $16.52. 2,832,695 shares of the stock were exchanged, compared to its average volume of 1,582,162. Sabra Health Care REIT has a 52-week low of $13.31 and a 52-week high of $20.03. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.16 and a quick ratio of 4.16. The company has a market capitalization of $3.91 billion, a price-to-earnings ratio of 40.29, a P/E/G ratio of 2.02 and a beta of 1.25. The company's 50-day moving average price is $16.98 and its two-hundred day moving average price is $17.62.

Sabra Health Care REIT Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 28th. Shareholders of record on Friday, February 14th will be given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 7.26%. The ex-dividend date is Friday, February 14th. Sabra Health Care REIT's payout ratio is 292.69%.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on SBRA shares. Mizuho reiterated a "neutral" rating and set a $20.00 price objective on shares of Sabra Health Care REIT in a research report on Thursday, December 5th. Truist Financial cut shares of Sabra Health Care REIT from a "buy" rating to a "hold" rating and lowered their price objective for the stock from $18.00 to $17.00 in a research report on Friday, January 17th. Citizens Jmp upgraded shares of Sabra Health Care REIT from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, January 7th. Finally, JMP Securities upgraded shares of Sabra Health Care REIT from a "market perform" rating to an "outperform" rating and set a $20.00 price target on the stock in a report on Tuesday, January 7th. Three equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $18.86.

About Sabra Health Care REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.